• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝裂原活化蛋白激酶对过氧化物酶体增殖物激活受体γ活性的调节

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.

作者信息

Camp H S, Tafuri S R

机构信息

Department of Cell Biology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.

出版信息

J Biol Chem. 1997 Apr 18;272(16):10811-6. doi: 10.1074/jbc.272.16.10811.

DOI:10.1074/jbc.272.16.10811
PMID:9099735
Abstract

Adipocyte differentiation is regulated both positively and negatively by external growth factors such as insulin, platelet-derived growth factor (PDGF), and epidermal growth factor (EGF). A key component of the adipocyte differentiation process is PPARgamma, peroxisomal proliferator-activated receptor gamma. To determine the relationship between PPARgamma activation and growth factor stimulation in adipogenesis, we investigated the effects of PDGF and EGF on PPARgamma1 activity. PDGF treatment decreased ligand-activated PPARgamma1 transcriptional activity in a transient reporter assay. In vivo [32P]orthophosphate labeling experiments demonstrated that PPARgamma1 is a phosphoprotein that undergoes EGF-stimulated MEK/mitogen-activated protein (MAP) kinase-dependent phosphorylation. Purified PPARgamma1 protein was phosphorylated in vitro by recombinant activated MAP kinase. Examination of the PPARgamma1 sequence revealed a single MAP kinase consensus recognition site at Ser82. Mutation of Ser82 to Ala inhibited both in vitro and in vivo phosphorylation and growth factor-mediated transcriptional repression. Therefore, phosphorylation of PPARgamma1 by MAP kinase contributes to the reduction of PPARgamma1 transcriptional activity by growth factor treatment.

摘要

脂肪细胞分化受到诸如胰岛素、血小板衍生生长因子(PDGF)和表皮生长因子(EGF)等外部生长因子的正向和负向调节。脂肪细胞分化过程的一个关键成分是PPARγ,即过氧化物酶体增殖物激活受体γ。为了确定PPARγ激活与脂肪生成中生长因子刺激之间的关系,我们研究了PDGF和EGF对PPARγ1活性的影响。在瞬时报告基因检测中,PDGF处理降低了配体激活的PPARγ1转录活性。体内[32P]正磷酸盐标记实验表明,PPARγ1是一种磷蛋白,其经历EGF刺激的MEK/丝裂原活化蛋白(MAP)激酶依赖性磷酸化。纯化的PPARγ1蛋白在体外被重组活化的MAP激酶磷酸化。对PPARγ1序列的检查揭示了Ser82处有一个单一的MAP激酶共有识别位点。将Ser82突变为Ala抑制了体外和体内的磷酸化以及生长因子介导的转录抑制。因此,MAP激酶对PPARγ1的磷酸化导致生长因子处理降低PPARγ1转录活性。

相似文献

1
Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.丝裂原活化蛋白激酶对过氧化物酶体增殖物激活受体γ活性的调节
J Biol Chem. 1997 Apr 18;272(16):10811-6. doi: 10.1074/jbc.272.16.10811.
2
c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity.c-Jun氨基末端激酶使过氧化物酶体增殖物激活受体γ1磷酸化,并对其转录活性起负调控作用。
Endocrinology. 1999 Jan;140(1):392-7. doi: 10.1210/endo.140.1.6457.
3
Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.胰岛素和丝裂原活化蛋白激酶介导的过氧化物酶体增殖物激活受体γ的磷酸化与激活
J Biol Chem. 1996 Dec 13;271(50):31771-4. doi: 10.1074/jbc.271.50.31771.
4
Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.
J Biol Chem. 1997 Feb 21;272(8):5128-32. doi: 10.1074/jbc.272.8.5128.
5
Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma.通过丝裂原活化蛋白激酶介导的过氧化物酶体增殖物激活受体γ磷酸化来抑制脂肪生成。
Science. 1996 Dec 20;274(5295):2100-3. doi: 10.1126/science.274.5295.2100.
6
3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.3-磷酸肌醇依赖性蛋白激酶-1激活过氧化物酶体增殖物激活受体γ并促进脂肪细胞分化。
Mol Endocrinol. 2006 Feb;20(2):268-78. doi: 10.1210/me.2005-0197. Epub 2005 Sep 8.
7
Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases.p38丝裂原活化蛋白激酶介导的NFATc4磷酸化作用。
Mol Cell Biol. 2002 Jun;22(11):3892-904. doi: 10.1128/MCB.22.11.3892-3904.2002.
8
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin.过氧化物酶体增殖物激活受体γ(PPARγ)N端的非配体依赖性激活结构域。PPARγ1和-2亚型的差异活性及胰岛素的影响。
J Biol Chem. 1997 Aug 8;272(32):20230-5. doi: 10.1074/jbc.272.32.20230.
9
The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells.过氧化物酶体增殖物激活受体γ1(PPARγ1)的铰链螺旋1区域介导与细胞外信号调节激酶5的相互作用及PPARγ1的转录激活:参与内皮细胞中血流诱导的PPARγ激活。
Mol Cell Biol. 2004 Oct;24(19):8691-704. doi: 10.1128/MCB.24.19.8691-8704.2004.
10
Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-gamma 1 gene expression in human aortic smooth muscle cells.早期生长反应因子-1是人类主动脉平滑肌细胞中过氧化物酶体增殖物激活受体γ1基因表达的关键转录调节因子。
J Biol Chem. 2002 Jul 26;277(30):26808-14. doi: 10.1074/jbc.M203748200. Epub 2002 May 13.

引用本文的文献

1
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications.黑色素瘤与免疫细胞中的过氧化物酶体增殖物激活受体γ:对疾病发病机制及治疗意义的见解
Cells. 2025 Apr 2;14(7):534. doi: 10.3390/cells14070534.
2
Analysis of an adult diabetes mellitus caused by a rare mutation of the gene: A case report.一例由罕见基因突变引起的成人糖尿病分析:病例报告
World J Clin Cases. 2024 Jul 6;12(19):3942-3949. doi: 10.12998/wjcc.v12.i19.3942.
3
Stellera chamaejasme L. extract inhibits adipocyte differentiation through activation of the extracellular signal-regulated kinase pathway.
柳叶菜提取物通过激活细胞外信号调节激酶通路抑制脂肪细胞分化。
PLoS One. 2024 Mar 21;19(3):e0300520. doi: 10.1371/journal.pone.0300520. eCollection 2024.
4
Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.人参皂苷Rg1通过抑制阿尔茨海默病神经元模型中的ERK/PPARγ磷酸化途径促进β-淀粉样肽的降解。
Exp Ther Med. 2023 Nov 23;27(1):31. doi: 10.3892/etm.2023.12319. eCollection 2024 Jan.
5
Docosahexaenoic Acid as Master Regulator of Cellular Antioxidant Defenses: A Systematic Review.二十二碳六烯酸作为细胞抗氧化防御的主要调节因子:一项系统综述
Antioxidants (Basel). 2023 Jun 15;12(6):1283. doi: 10.3390/antiox12061283.
6
Impaired PPARγ activation by cadmium exacerbates infection-induced lung injury.镉抑制 PPARγ 激活加剧感染诱导的肺损伤。
JCI Insight. 2023 May 8;8(9):e166608. doi: 10.1172/jci.insight.166608.
7
PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer.过氧化物酶体增殖物激活受体-γ 部分激动剂在疾病命运决策中的作用,特别关注癌症。
Cells. 2022 Oct 13;11(20):3215. doi: 10.3390/cells11203215.
8
Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases.神经氨酸酶-1:一种参与癌症和代谢性疾病发展的唾液酸酶
Cancers (Basel). 2022 Oct 5;14(19):4868. doi: 10.3390/cancers14194868.
9
Therapeutic Target Analysis and Molecular Mechanism of Melatonin - Treated Leptin Resistance Induced Obesity: A Systematic Study of Network Pharmacology.褪黑素治疗瘦素抵抗诱导肥胖的治疗靶点分析及分子机制:网络药理学的系统研究。
Front Endocrinol (Lausanne). 2022 Jul 22;13:927576. doi: 10.3389/fendo.2022.927576. eCollection 2022.
10
Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib.糖原贮积病 Ib 型中性粒细胞分化异常的分子机制。
Cell Mol Life Sci. 2022 Apr 18;79(5):246. doi: 10.1007/s00018-022-04267-5.